Clinical Trials Browser

Stomach Neoplasms

Anal Canal Carcinoma, Anus Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gallbladder Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Nasopharyngeal Carcinoma, Recurrence

Stomach Neoplasms

Nasopharyngeal Neoplasms

Rectal Neoplasms

Stomach Neoplasms

Breast Neoplasms

Breast Neoplasms

Rectal Neoplasms

Somatostatinoma, Carcinoma, Neuroendocrine

Rectal Neoplasms

Esophageal Squamous Cell Carcinoma

Pancreatic Neoplasms

Colorectal Neoplasms

Colonic Neoplasms

Rectal Neoplasms

Adenocarcinoma, Rectal Neoplasms

Adenocarcinoma of the Oesophagus

Breast Neoplasm Malignant Female

Colorectal Neoplasms

Breast Neoplasms

Nasopharyngeal Carcinoma

Adenoma, Islet Cell

Locally Advanced Rectal Cancer

Breast Neoplasms

Cholangiocarcinoma

Colorectal Neoplasms

Gallbladder Neoplasms, Klatskin Tumor

Stomach Neoplasms

DMMR Colorectal Cancer

Stomach Neoplasms

Triple Negative Breast Neoplasms

Colorectal Neoplasms

Breast Neoplasms

Clinical Trials

A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma

A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction

ALTER-HN005

A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer

Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer

Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

MK-7119-001

Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

Colon Neoadjuvant FOLFOXIRI Study

Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma

MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer

A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

NOAHS-ARC

PLATFORM

DPDMAX

Toco-CoR

ORCHID

Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma

Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

SAFIR02_Breast

PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After Surgery

AXOAXI

Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer

CRITICS-II

PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer

Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer

Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer